Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

{ 'indexed': {'date-parts': [[2024, 4, 8]], 'date-time': '2024-04-08T08:29:42Z', 'timestamp': 1712564982928}, 'reference-count': 23, 'publisher': 'Elsevier BV', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2020, 7, 1]], 'date-time': '2020-07-01T00:00:00Z', 'timestamp': 1593561600000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 7, 24]], 'date-time': '2021-07-24T00:00:00Z', 'timestamp': 1627084800000}, 'content-version': 'am', 'delay-in-days': 388, 'URL': 'http://www.elsevier.com/open-access/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 7]]}, 'DOI': '10.1016/j.ijantimicag.2020.105949', 'type': 'journal-article', 'created': {'date-parts': [[2020, 3, 20]], 'date-time': '2020-03-20T16:28:15Z', 'timestamp': 1584721695000}, 'page': '105949', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 3245, 'title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label ' 'non-randomized clinical trial', 'prefix': '10.1016', 'volume': '56', 'author': [ {'given': 'Philippe', 'family': 'Gautret', 'sequence': 'first', 'affiliation': []}, {'given': 'Jean-Christophe', 'family': 'Lagier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Parola', 'sequence': 'additional', 'affiliation': []}, {'given': 'Van Thuan', 'family': 'Hoang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Line', 'family': 'Meddeb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Morgane', 'family': 'Mailhe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Barbara', 'family': 'Doudier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Johan', 'family': 'Courjon', 'sequence': 'additional', 'affiliation': []}, {'given': 'Valérie', 'family': 'Giordanengo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vera Esteves', 'family': 'Vieira', 'sequence': 'additional', 'affiliation': []}, {'given': 'Hervé', 'family': 'Tissot Dupont', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stéphane', 'family': 'Honoré', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Colson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eric', 'family': 'Chabrière', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernard', 'family': 'La Scola', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Marc', 'family': 'Rolain', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Brouqui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Didier', 'family': 'Raoult', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.ijantimicag.2020.105949_bib0001', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105924', 'article-title': 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ' 'coronavirus disease-2019 (COVID-19): The epidemic and the challenges', 'author': 'Lai', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0002', 'article-title': 'A review of the 2019 Novel Coronavirus (COVID-19) based on current ' 'evidence”', 'author': 'Wang', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0003', 'unstructured': "WHO Director-General's opening remarks at the media briefing on COVID-19 " '- 11 March 2020. ' '[https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020]'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0004', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jama.2020.2648', 'article-title': 'Characteristics of and important lessons from the coronavirus disease ' '2019 (COVID-19) outbreak in China: summary of a report of 72\xa0314 ' 'cases from the Chinese Center for Disease Control and Prevention', 'author': 'Wu', 'year': '2020', 'journal-title': 'JAMA'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0005', 'unstructured': 'Santé Publique France. Infection au nouveau Coronavirus (SARS-CoV-2), ' 'COVID-19, France et Monde ' '[https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/articles/infection-au-nouveau-coronavirus-sars-cov-2-covid-19-france-et-monde]'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0006', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105923', 'article-title': 'Chloroquine for the 2019 novel coronavirus SARS-CoV-2', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0007', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105932', 'article-title': 'Chloroquine and hydroxychloroquine as available weapons to fight ' 'COVID-19', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0008', 'first-page': '10', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0009', 'doi-asserted-by': 'crossref', 'DOI': '10.5582/bst.2020.01047', 'article-title': 'Breakthrough: Chloroquine phosphate has shown apparent efficacy in ' 'treatment of COVID-19 associated pneumonia in clinical studies', 'author': 'Gao', 'year': '2020', 'journal-title': 'Biosci Trends'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0010', 'unstructured': 'Chinese Clinical Trial Registry. ' 'http://www.chictr.org.cn/searchproj.aspx?title=%E6%B0%AF%E5%96%B9&officialname=&subjectid=&secondaryid=&applier=&studyleader=&ethicalcommitteesanction=&sponsor=&studyailment=&studyailmentcode=&studytype=0&studystage=0&studydesign=0&minstudyexecutetime=&maxstudyexecutetime=&recruitmentstatus=0&gender=0&agreetosign=&secsponsor=&regno=&regstatus=0&country=&province=&city=&institution=&institutionlevel=&measure=&intercode=&sourceofspends=&createyear=0&isuploadrf=&whetherpublic=&btngo=btn&verifycode=&page=1.'}, { 'issue': '3', 'key': '10.1016/j.ijantimicag.2020.105949_bib0011', 'first-page': '185', 'article-title': 'Expert consensus on chloroquine phosphate for the treatment of novel ' 'coronavirus pneumonia]', 'volume': '43', 'year': '2020', 'journal-title': 'Zhonghua Jie He He Hu Xi Za Zhi'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0012', 'doi-asserted-by': 'crossref', 'first-page': '2845', 'DOI': '10.1021/jm0601856', 'article-title': 'Design and synthesis of hydroxyferroquine derivatives with antimalarial ' 'and antiviral activities', 'volume': '49', 'author': 'Biot', 'year': '2006', 'journal-title': 'J Med Chem'}, { 'issue': '6', 'key': '10.1016/j.ijantimicag.2020.105949_bib0013', 'doi-asserted-by': 'crossref', 'first-page': '1386', 'DOI': '10.1016/j.ophtha.2016.01.058', 'article-title': 'Recommendations on Screening for Chloroquine and Hydroxychloroquine ' 'Retinopathy (2016 Revision)', 'volume': '123', 'author': 'Marmor', 'year': '2016', 'journal-title': 'Ophthalmology'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0014', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In Vitro Antiviral Activity and Projection of Optimized Dosing Design ' 'of Hydroxychloroquine for the Treatment of Severe Acute Respiratory ' 'Syndrome Coronavirus 2 (SARS-CoV-2)', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'issue': '2', 'key': '10.1016/j.ijantimicag.2020.105949_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '167', 'DOI': '10.1001/archinte.159.2.167', 'article-title': 'Treatment of Q fever endocarditis: comparison of 2 regimens containing ' 'doxycycline and ofloxacin or hydroxychloroquine', 'volume': '159', 'author': 'Raoult', 'year': '1999', 'journal-title': 'Arch Intern Med'}, { 'issue': '6', 'key': '10.1016/j.ijantimicag.2020.105949_bib0016', 'doi-asserted-by': 'crossref', 'first-page': '463', 'DOI': '10.1097/QCO.0000000000000489', 'article-title': "Whipple's disease and Tropheryma whipplei infections: when to suspect " 'them and how to diagnose and treat them', 'volume': '31', 'author': 'Lagier', 'year': '2018', 'journal-title': 'Curr Opin Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0017', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101632', 'article-title': 'Rapid viral diagnosis and ambulatory management of suspected COVID-19 ' 'cases presenting at the infectious diseases referral hospital in ' 'Marseille, France, - January 31st to March 1st, 2020: A respiratory ' 'virus snapshot', 'author': 'Amrane', 'year': '2020', 'journal-title': 'Travel Med Infect Dis'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0018', 'doi-asserted-by': 'crossref', 'first-page': '166', 'DOI': '10.1016/j.jchromb.2017.06.011', 'article-title': 'Simultaneous UHPLC-UV analysis of hydroxychloroquine, minocycline and ' 'doxycycline from serum samples for the therapeutic drug monitoring of Q ' "fever and Whipple's disease", 'volume': '1060', 'author': 'Armstrong', 'year': '2017', 'journal-title': 'J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.'}, { 'key': '10.1016/j.ijantimicag.2020.105949_bib0019', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}, { 'issue': '50', 'key': '10.1016/j.ijantimicag.2020.105949_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '14408', 'DOI': '10.1073/pnas.1618029113', 'article-title': 'Zika virus cell tropism in the developing human brain and inhibition by ' 'azithromycin', 'volume': '113', 'author': 'Retallack', 'year': '2016', 'journal-title': 'Proc Natl Acad Sci U S A'}, { 'issue': '7', 'key': '10.1016/j.ijantimicag.2020.105949_bib0021', 'doi-asserted-by': 'crossref', 'first-page': '317', 'DOI': '10.1021/acsinfecdis.5b00030', 'article-title': 'Evaluation of Ebola Virus Inhibitors for Drug Repurposing', 'volume': '1', 'author': 'Madrid', 'year': '2015', 'journal-title': 'ACS Infect Dis'}, { 'issue': '1', 'key': '10.1016/j.ijantimicag.2020.105949_bib0022', 'doi-asserted-by': 'crossref', 'first-page': '6', 'DOI': '10.4172/1948-5964.1000173', 'article-title': 'Azithromycin inhibits the replication of Zika virus', 'volume': '10', 'author': 'Bosseboeuf', 'year': '2018', 'journal-title': 'J Antivirals Antiretrovirals'}, { 'issue': '19', 'key': '10.1016/j.ijantimicag.2020.105949_bib0023', 'doi-asserted-by': 'crossref', 'first-page': '2034', 'DOI': '10.1001/jama.2015.13896', 'article-title': 'Early administration of azithromycin and prevention of severe lower ' 'respiratory tract illnesses in preschool children with a history of ' 'such illnesses: A randomized clinical trial', 'volume': '314', 'author': 'Bacharier', 'year': '2015', 'journal-title': 'JAMA'}], 'container-title': 'International Journal of Antimicrobial Agents', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920300996?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S0924857920300996?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 7, 3]], 'date-time': '2022-07-03T15:56:06Z', 'timestamp': 1656863766000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S0924857920300996'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 7]]}, 'references-count': 23, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2020, 7]]}}, 'alternative-id': ['S0924857920300996'], 'URL': 'http://dx.doi.org/10.1016/j.ijantimicag.2020.105949', 'relation': { 'has-review': [ { 'id-type': 'doi', 'id': '10.3410/f.737589198.793573012', 'asserted-by': 'object'}, { 'id-type': 'doi', 'id': '10.3410/f.737589198.793575483', 'asserted-by': 'object'}, { 'id-type': 'doi', 'id': '10.3410/f.737589198.793575078', 'asserted-by': 'object'}, { 'id-type': 'doi', 'id': '10.3410/f.737589198.793575992', 'asserted-by': 'object'}], 'has-preprint': [ { 'id-type': 'doi', 'id': '10.1101/2020.03.16.20037135', 'asserted-by': 'object'}]}, 'ISSN': ['0924-8579'], 'subject': ['Pharmacology (medical)', 'Infectious Diseases', 'Microbiology (medical)', 'General Medicine'], 'container-title-short': 'International Journal of Antimicrobial Agents', 'published': {'date-parts': [[2020, 7]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an ' 'open-label non-randomized clinical trial', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'International Journal of Antimicrobial Agents', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.ijantimicag.2020.105949', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, {'value': '© 2020 Published by Elsevier B.V.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '105949'}